Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer

Published:2007-05-05 Issue:3 Volume:61 Page:503-508
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Ohyanagi Fumiyoshi,Horiike Atsushi,Okano Yoshio,Satoh Yukitoshi,Okumura Sakae,Ishikawa Yuichi,Nakagawa Ken,Horai Takeshi,Nishio Makoto

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-007-0496-6.pdf

Reference25 articles.

1. Stupp R, Monnerat C, Turrisi AT 3rd et al (2004) Small cell lung cancer: state of the art and future perspectives. Lung Cancer 45:105–117

2. Noda K, Nishiwaki Y, Kawahara M et al (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85–91

3. von Pawel J, Schiller JH, Shepherd FA et al (1999) Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 17:658–667

4. Argiris A, Murren JR (2001) Advances in chemotherapy for small cell lung cancer: single-agent activity of newer agents. Cancer J 7:228–235

5. Noble S, Goa KL (1997) Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs 54:447–472

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment strategy for patients with relapsed small-cell lung cancer: past, present and future;Translational Lung Cancer Research;2020-04

2. UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis;Cancer Chemotherapy and Pharmacology;2017-06-05

3. Differenzialtherapie des fortgeschrittenen metastasierten kleinzelligen Lungenkarzinoms;Der Onkologe;2017-04-04

4. Prise en charge thérapeutique des tumeurs neuroendocrines peu différenciées pulmonaires et des carcinomes neuroendocrines digestifs;Bulletin du Cancer;2016-10

5. Effects of UGT1A1*6, UGT1A1*28, and ABCB1-3435C>T polymorphisms on irinotecaninduced toxicity in Chinese cancer patients;Int. Journal of Clinical Pharmacology and Therapeutics;2016-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3